References
- Sawitsky A., Rai K. R., Glidewell O., Silver R. T. and participating members of CALGB. Blood 1977; 50: 1049–59
- French Cooperative Group on Chronic Lymphocytic Leukaemia. Effectiveness of “CHOP” regimen in advanced untreated chronic lymphocytic leukaemia. Lancet 1986; II: 1346–9
- Raphael B., Andersen J. W., Silber R., Oken M., Moore D., Bennett J., Bonner H., Hahn R., Knospe W. H., Mazza J., Glick J. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: Long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. Journal of Clinical Oncology 1991; 9: 770–6
- Hansen M M., Andersen E., Birgens H., Christensen B. E., Christensen T. G., Geisler C, Meldgaard K., Pedersen D. CHOP versus chlorambucil + prednisolone in chronic lymphocytic leukemia. Leukemia and Lymphoma 1991; 5(suppl.)97–100
- Hansen S. W., Nissen N. I., Hansen M. M., Hou-Jensen K., Pedersen-Bjergaard J. High activity of mitoxan-trone in previously untreated low-grade lymphomas. Cancer Chemotherapy and Pharmacology 1988; 22: 77–9
- Moules I. K. Clinical tolerance of Novantrone. the 2nd United Kingdom Novantrone Symposium. Lederle Laboratories, Great Britain 1986; 145–51
- Montserrat E., Alcalá A., Alonso C., Besalduch J., Moraleda J. M., Conde J., Gutierrez M., Gomis F., Garijo J., Guzman M., Estapé J., Rozman C. and participating members of Pethema, Spanish Society of Hematology 1988. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C. Nouvelle Revue Francaise d'Hematologie, 30: 429–32
- Jaksić B., Brugiatelli M. High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL-IGCI CLL-01 trial. Nouvelle Revue Francaise d ‘Hematologic’ 1988; 30: 437–42
- French Cooperative Group on Chronic Lymphocytic Leukemia. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Nouvelle Revue Francaise d ‘Hematologic’ 1988; 30: 449–52
- Catovsky D., Richards S., Fooks J., Hamblin T. J. on behalf of the MRC Working Party on Leukaemia in Adults. CLL trials in the United Kingdom. The Medical Research Council CLL Trials. Leukemia and Lymphoma 1991; 5(suppl.)105–12
- Keating M. J. Fludarabine Phosphate in the treatment of chronic lymphocytic leukemia. Seminars in Oncology 1990; 17(suppl.)49–62